|
 |
ArimidexThis page contains recent news articles, when available, and an overview of Arimidex but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Arimidex (when available) Anastrozole is a potent and selective non-steroidal aromatase inhibitor indicated for the treatment of advanced breast cancer in post-menopausal women with disease progression following tamoxifen therapy. Many breast cancers have estrogen receptors and growth of these tumors can be stimulated by estrogens. In post-menopausal women, the principal source of circulating estrogen (primarily estradiol) is conversion of adrenally-generated androstenedione to estrone by aromatase in peripheral tissues, such as adipose tissue, with further conversion of estrone to estradiol. Many breast cancers also contain aromatase; the importance of tumor-generated estrogens is uncertain. Treatment of breast cancer has included efforts to decrease estrogen levels by ovariectomy premenopausally and by use of anti-estrogens and progestational agents both pre- and post-menopausally, and these interventions lead to decreased tumor mass or delayed progression of tumor growth in some women. Anastrozole is a potent and selective non-steroidal aromatase inhibitor. It significantly lowers serum estradiol concentrations and has no detectable effect on formation of adrenal corticosteroids or aldosterone. For treatment of advanced breast cancer. Mechanism Of Action: Anastrozole selectively inhibits aromatase. The principal source of circulating estrogen (primarily estradiol) is conversion of adrenally-generated androstenedione to estrone by aromatase in peripheral tissues. Therefore, aromatase inhibition leads to a decrease in circulatin estrogen, leading to a decreased tumor mass or delayed progression of tumor growth in some women. News Articles on Anastrozole Why piling eye drops high can make a lot of sense to Novartis - 04 Jan 2010 AstraZeneca's billion-dollar breast cancer drug, Arimidex, comes off patent in June. AstraZeneca is sticking to its knitting of developing exotic compounds ... Times Online ê´€ì ˆí†µìœ¼ë¡œ '아리미ë?±ìŠ¤' 사용 불가 'ë ˆíŠ¸ë¡œì¡¸'ë¡œ 바꾸세요 - 04 Jan 2010 ...아리미ë?±ìŠ¤(Arimidex, anastrozole) 사용과 ì—°ê´€ë?œ 류마티스성 ì¦?ìƒ?ì?´ 있는 ìœ ë°©ì•”ì?„ 앓는 환ìž?ì?˜ 경우 아리미ë?±ìŠ¤ ëŒ€ì‹ ë ˆíŠ¸ë¡œì¡¸(Letrozole) ë¡œ 약물ì?„ 바꾸는 것ì?´ ... 메디컬투데이 Commercial Insight: Antihormonal Cancer Therapies - New Report Published - Jan 3, 2010 These will remain the top three brands through to 2018, even though Arimidex and Casodex will lose around 40% of their brand value due to generic ... OfficialWire (press release) Some Brand-Name Patents: Going, Going, Gone in 2010 - Dec 29, 2009 AstraZeneca's breast cancer treatment Arimidex isn't quite as big a seller as Cozaar and Hyzaar, but it's still a blockbuster bringing in $1.4 billion ... Motley Fool Non-adherence Rate for Adjuvant Hormonal Therapy for Breast Cancer is 40% - Dec 29, 2009 Researchers from Germany have also reported that postmenopausal women with localized breast cancer taking adjuvant Arimidex® (anastrozole) for localized ... Cancer Consultants SABCS: Vitamin D Reduces Aromatase Inhibitor Pain - Dec 15, 2009 ...joint pain in breast cancer patients treated with the aromatase inhibitor anastrozole (Arimidex), results of a small, randomized clinical trial showed. ... MedPage Today Aromatase inhibition increased testosterone, decreased estradiol, BMD in older men - Dec 23, 2009 ...borderline or low testosterone levels and symptoms of hypogonadism were randomly assigned to 1-mg anastrozole (Arimidex, AstraZeneca) or placebo daily. ... Endocrine Today Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May ... - Dec 10, 2009 ARIMIDEX is approved for adjuvant treatment (treatment following surgery with or without radiation) of postmenopausal women with hormone receptor-positive ... CNNMoney.com (press release) Tamoxifen, Endoxifen, and CYP2D6: The Rules for Evaluating a Predictive Factor - Dec 17, 2009 ...unadjusted hazard ratio (HR) of 2.12, which was significantly larger than the HR of tamoxifen relative to anastrozole (1.31) in the Arimidex, Tamoxifen, ... Cancer Network Dr. Bill Elliott: Soy-breast cancer link questioned - Dec 13, 2009 ...have been diagnosed with breast cancer one of the cornerstones of breast cancer treatment are estrogen-blocking drugs such as tamoxifen and arimidex. ... Marin Independent-Journal Nexavar to make breast cancer drugs work longer - Dec 12, 2009 Aromatase inhibitors include anastrozole, made by AstraZeneca under the brand name Arimidex, and exemestane, made by Pfizer Inc, under the brand name ... TopNews United States SABCS: Higher Dose of Fulvestrant Slows Breast Cancer - Dec 14, 2009 Results of another multinational study demonstrated no advantage for adding fulvestrant to anastrozole (Arimidex). Time to progression and overall survival ... MedPage Today Follow-up Presented of Nexavar® plus Taxol® Study for Treatment of Advanced ... - Dec 17, 2009 ...treatment of breast cancer; however, researchers have speculated that Nexavar may aid in reversing the resistance to Arimidex or other hormone agents. ... Cancer Consultants Bisphosphonates and Beyond: Managing Bone Density and Reducing Breast Cancer - Dec 12, 2009 Anastrozole, currently sold as Arimidex by AstraZeneca, is scheduled to go off patent within the next few years. "Women who are on Medicare tend to go with ... Healthcanal.com Police and Fire reports: 11/12/09 - Nov 12, 2009 Altogether, 30 pills, or $300 worth, of Arimidex was stolen. A chopsaw was reported stolen Tuesday afternoon from Home Depot. The saw was left in a vehicle ... Red Bluff Daily News Generic Name: Anastrozole, cancer - Nov 11, 2009 Arimidex is approved for postmenopausal women with hormone receptor-positive early breast cancer. Arimidex is a hormonal treatment that helps fight breast ... Pattaya Daily News Agenda: Astra Zeneca Feeling Some Pain - Oct 28, 2009 The drugs in question are Toprol, Casodex, Arimidex, Pulmicort and Merrem. This is not a comfortable position to be in. AZ announces its third quarter ... Wall Street Journal (blog) Over 65? Why some doctors think giving you the latest cancer drugs is just a waste - Nov 2, 2009 ...prescription for hormonal treatments such as Tamoxifen or Arimidex, which suppress the female hormone oestrogen and slow down the growth of the cancer. ... Daily Mail Commercial Insight: Antihormonal Cancer Therapies - Stagnant sales indicative ... - Oct 30, 2009 These will remain the top three brands through to 2018, even though Arimidex and Casodex will lose around 40% of their brand value due to generic ... PRMinds (press release) Teaching about breast cancer, one bead at a time - Oct 30, 2009 Chemotherapy followed and, four years later, Hayward still takes an Arimidex pill once a day to attack any nascent cancer cells. Following her diagnosis ... Ipswich Chronicle BREAKING NEWS: AstraZeneca sales boosted by swine flu vaccine - Oct 29, 2009 Turnover of the breast cancer drug Arimidex (anastrozole) were up 2% to $476 million, while generic competition to Casodex (bicalutamide) saw the drug fall ... Pharma Times Transcript Of Live Chat With Doctors - Oct 28, 2009 AND YOU SHULD DISCUSS THE PROS AND CONS OF CHEMO WITH YOUR ONCOLOGIST MARY I am a breast cancer survivor and about to conclude 5 years on Arimidex. ... WFSB Fighting breast cancer together - Oct 24, 2009 Now, two years later, according to all tests and PET scans, Leigh is cancer-free, although she has another year of taking arimidex, an anti-breast cancer ... Sarasota Herald-Tribune РБК-ТВ: БританÑ?каÑ? фармацевтичеÑ?каÑ? компаниÑ? AstraZeneca раÑ?Ñ?матривает ... - Oct 27, 2009 как Arimidex (длÑ? лечениÑ? раковых опухолей), Nexium (длÑ? лечениÑ? заболеваний желудочно-кишечного тракта) и Symbicort (противоаÑ?тматичеÑ?кий препарат). ... РБК - РИА РосБизнесКонсалтинг Aromasin nel trattamento del tumore al seno a insorgenza precoce - Nov 4, 2009 ...portato allo sviluppo degli inibitori dell'aromatasi di terza generazione, Anastrozolo ( Arimidex ), Letrozolo ( Femara ) ed Exemestane ( Aromasin ). ... XagenaSalute æ—¥ ì œë„¤ë¦ ì‹œìž¥ '외ìž?사 진출러시' - Nov 2, 2009 ...ê·¸ë¦¬ê³ 2011ë…„ì—? 'ë¦¬í”¼í† '(Lipitor, atorvastatin), 'ì•¡í† ìŠ¤'(Actos, pioglitazone), '미ë?¼íŽ™ìŠ¤'(Mirapex, pramipexole)ê°€, 2012ë…„ì—” '아리미ë?±ìŠ¤'(Arimidex, ... 디지틀보사 Brand Names/Synonyms: Arimidex is also known by the following brand names and/or synonymsAnastrole; Anastrozol; Anastrozole; Anastrozole [Usan:Ban:Inn]; Arimidex; CHEMBANK1630; ICI-D 1033; ZD 1033 Drug Category: Arimidex is categorized under the following by the FDA: Antineoplastic Agents; ATC:L02BG03 Dosage Forms: tablets containing 1mg anastrozole Absorption: Absorbed into the systemic cirulation, and food does not affect the extent of absorption. Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 2-[3-(1-cyano-1-methyl-ethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)phenyl]-2-methyl-propanenitrile |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |